OMODEI, Umberto
 Distribuzione geografica
Continente #
NA - Nord America 3.289
EU - Europa 1.102
AS - Asia 695
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 5.100
Nazione #
US - Stati Uniti d'America 3.287
UA - Ucraina 536
CN - Cina 403
DE - Germania 210
FI - Finlandia 109
IN - India 108
HK - Hong Kong 102
IT - Italia 78
IE - Irlanda 73
SG - Singapore 66
GB - Regno Unito 57
FR - Francia 24
TR - Turchia 11
BR - Brasile 7
SE - Svezia 6
BE - Belgio 5
EU - Europa 5
AU - Australia 2
CA - Canada 2
KR - Corea 2
AZ - Azerbaigian 1
BD - Bangladesh 1
BY - Bielorussia 1
JO - Giordania 1
NL - Olanda 1
RO - Romania 1
RU - Federazione Russa 1
Totale 5.100
Città #
Fairfield 473
Woodbridge 464
Jacksonville 362
Houston 347
Ann Arbor 286
Ashburn 263
Cambridge 214
Seattle 203
Wilmington 191
Princeton 146
Nanjing 111
Hong Kong 102
Dublin 73
Chandler 71
Beijing 56
Dearborn 53
Helsinki 37
Singapore 37
Nanchang 31
Milan 25
San Diego 25
Changsha 22
Jiaxing 20
Jinan 20
Kunming 20
Hebei 19
Tianjin 18
Brescia 17
Shenyang 16
Washington 15
Los Angeles 12
Hangzhou 11
Boardman 10
Kocaeli 10
London 10
Shanghai 9
Verona 9
Hefei 8
Ningbo 8
Indiana 7
New York 7
Norwalk 7
San Francisco 7
Guangzhou 6
Lanzhou 6
Brussels 5
Des Moines 4
Orange 4
Taiyuan 4
Zhengzhou 4
Haikou 3
Nürnberg 3
Ronchi Dei Legionari 3
Berlin 2
Fuzhou 2
Paceco 2
San Giacomo delle Segnate 2
Taizhou 2
Walnut 2
Yellow Springs 2
Amman 1
Augusta 1
Baku 1
Bardolino 1
Chaoyang 1
Dhaka 1
Falkenstein 1
Frankfurt am Main 1
Horia 1
Hounslow 1
Huntersville 1
Kilburn 1
Markham 1
Melbourne 1
Minsk 1
New Bedfont 1
New Delhi 1
Padenghe sul Garda 1
Paris 1
Redmond 1
Saint Petersburg 1
Santa Clara 1
Southwark 1
Sydney 1
Toronto 1
Verderio Inferiore 1
Wandsworth 1
Totale 3.935
Nome #
Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women 132
Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users. 118
FSH receptor polymorphisms in a population of infertile women and controls 112
Identification of osteoporosis risk in postmenopausal women by the combined use of ultrasounds and clinical factors 109
Can salin infusion sonohysterography (SIS) replace diagnostic hysteroscopy in the uterine cavity evaluation of infertile women? 108
General and medical factors associated with hormone replacement therapy among women attending menopause clinics in Italy 105
Clinical Impact of a New Italian Law Regulation on Assisted Reproduction Technologies 102
Risk identification of osteoporosis in postmenopausal women by a simple algorithm based on ultrasound densitometry and body mass index 100
Risk factors for clinically diagnosed uterine fibroids in women around menopause. 100
Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries 99
Effect of acupuncture on rates of pregnancy among women undergoing in vitro fertilization 99
Factors associated with total cholesterol levels in women around menopause attending menopause clinics in Italy 99
Determinants of body mass index in women around menopause attending menopause clinics in Italy. 98
How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study. 94
Effect of soy-derived isoflavones on hot flashes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries 91
Risk factors for type 2 diabetes in women attending menopause clinics in Italy: a cross-sectional study. 90
Risk of low bone density in women attending menopause clinics in Italy 90
A New HRT Regimen Using Estradiol Valerate and Cyproterone Acetate: Clinical Data 89
Risk factors for high blood pressure in women attending menopause clinics in Italy. 88
Endometrial thickness and histological abnormalities in women on hormonal replacement therapy: a transvaginal ultrasound/hysteroscopic study 87
Chromosome Abnormalities and Yq microdeletions in Infertile italian couples referred for assisted reproductive tecnique 86
Determinants of age at menopause in women attending menopause clinics in Italy. 86
A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers. 85
Serum progesterone level on the day of oocyte retrieval correlates with the ovarian response but not predict pregnancy rate 85
The Effect of HRT on Endometrial Thickness (ET) and Uterine Arterial Blood Flow Assessed by Transvaginal Ultrasound (TVU). 85
Ovulation induction with intravenous gonadotropin-releasing hormone 85
Osteoporosis Risk Profile for Peri-and Postmenopausal Women Attending Menopause Clinics in Italy 84
Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003. 83
Sequential Conjugated Estrogens Plus Medrogestone HRT Regimen Versus Tibolone: A Comparative Randomized Study 83
Endometrial evaluation with transvaginal ultrasound during hormone therapy: a prospective multicenter study. 81
Frequency of Cardiovascular Risks Factor in Women Attending Menopause Clinics: Findings from the ICARUS Data Base 81
Endometrial Changes and Doppler Flow Evaluation in Postmenopausal Breast Cancer Patients on Tamoxifen (TAM): A Transvaginal Ultrasound (TVU)/Hysterescopy Study 81
A New HRT Regimen Using Estradiol Valerate and Cyproterone Acetate: Impact on Lipid Metabolism 80
A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: The HOT study 80
Risk of low bone density in women attending menopause clinics in Italy. 79
Factors associated with climacteric symptoms in women around menopause attending menopause clinics in Italy. 79
Premature ovarian failure: frequency and risk factors among women attending a network of menopause clinics in Italy. 75
Risk factors for genital prolapse in non-hysterectomized women around menopause. Results from a large cross-sectional study in menopausal clinics in Italy 67
Treatment of hypothalamic infertility with pulsatile GN-RH administration. 65
CUMCS: FINDINGS FROM THE ICARUS DATA BASE 63
Profiles and endocrine correlations in endometrial carcinoma. 62
A new method for free testosterone assay: clinical evaluation. 58
Pituitary microprolactinoma, bromocriptine, and pregnancy: follow-up of 74 cases 58
Endometrial Evaluation in Postmenopausal Bleeding: Transvaginal Sonografy Versus Hysteroscopy 57
Anti-Mullerian hormone (AMH): Prognostic value in assisted reproductive technology (ART) 56
A new method for free testosterone assay: clinical evaluation. 54
Doppler flow evaluation of endometrial conditions in postmenopausal breast cancer patients treated with tamoxifen 52
Continuous combined HRT in post-menopause: two regimen comparative study 49
Treatment of hypothalamic infertility with pulsatile GN-RH administration. 49
The effect of HRT on uterine arterial blood flow in postmenopausal women assessed by transvaginal color doppler sonography (TVDS) 49
Profiles and endocrine correlations in endometrial carcinoma. 48
Polycystic ovary syndrome: long-term evolution. 48
The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trial 48
Ovarian hyperstimulation syndrome (OHS): a case of severe OHS. 47
Doppler flow evaluation of endometrial conditions in postmenopausal breast cancer patients treated with tamoxifen 47
Rischio oncologico 47
Outlook on Continuous Estrogen-Progestin Therapy. 46
The impact of HRT on endometrial thickness—do cut‐off values exist? 46
Endometrial ultrasound transvaginal (TVU) assessment in postmenopausal women on hormone replacement therapy (HRT) 46
Polycystic ovary syndrome: long-term evolution. 46
Treatment of hypothalamic infertility with pulsatile GN-RH administration. 46
Effects of Recombinant Follicle-Stimulating Hormone on Bone Turnover Markers in Infertile Women Undergoing in Vitro Fertilization Procedure 44
Premarin 0.625 vs Estraderm TTS 50 Have These Two" Standard Doses" the Same Biological Effects? 43
Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen: a transvaginal ultrasound study 41
EVALUATION OF BLEEDING AND CONTROL OF CLIMACTERIC SYMPTOMS OBSERVED WITH TWO TRANSDERMAL PREPARATIONS CONTAINING ESTRADIOL AND NORETHISTERONE ACETATE 41
Endometrial ultrasound transvaginal (TVU) assessment in postmenopausal women on hormone replacement therapy (HRT) 41
Fibrocystic Disease of the Breast Associated with Pituitary‐Ovarian Dysfunction: Results of Treatment with Bromocriptine 40
EFFECTS OF SOY-DERIVED ISOFLAVONES ON HOT FLUSHES AND VASCULAR REACTIVITY 39
Mammella: è possibile la chemioprevenzione? 39
Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen: a transvaginal ultrasound study 38
The effect of HRT on uterine arterial blood flow in postmenopausal women assessed by transvaginal color doppler sonography (TVDS) 38
La patologia endometriale e la sorveglianza della paziente in postmenopausa 37
Identificazione del rischio di osteoporosi in donne in postmenopausa mediante l’uso combinato di ultrasuoni e fattori clinici. 36
Totale 5.139
Categoria #
all - tutte 21.362
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.362


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.547 228 42 45 197 76 185 160 165 95 193 60 101
2020/2021911 5 136 9 103 23 142 25 144 105 102 98 19
2021/2022460 14 119 3 28 1 40 27 39 35 52 8 94
2022/2023296 75 1 6 27 20 100 0 19 26 3 6 13
2023/2024378 10 2 35 43 22 46 18 12 103 20 2 65
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 5.139